Companies / BOC Sciences / Sacituzumab
BOC Sciences

Sacituzumab | BOC Sciences

Sacituzumab is a humanized monoclonal antibody directed against Trop-2. Sacituzumab has been used in the research of metastatic triple-negative breast cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.